Fragile X syndrome: Examination of issues pertaining to population-based screening

Screening

Volumn 4, Issue 4, 1996, Pages 175-192

  Meadows, K L ^a   Sherman, S L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Fragile X syndrome; Population based screening

Indexed keywords

ADULT; AGE; ARTICLE; DISEASE CARRIER; FEMALE; FRAGILE X SYNDROME; HUMAN; MENTAL DEFICIENCY; NEWBORN; POPULATION GENETICS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING;

EID: 0029975251     PISSN: 09256164     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-6164(95)00126-3     Document Type: Article

References (77)

1. Verkerk AJMH Pieretti M Sutcliffe JS Fu Y Kuhl DPA Pizzuti A Reiner O Richards S Victoria MF Zhang F Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome Cell 65 1991 905
2. Fu YH Kuhl DPA Pizzuti A Pieretti M Sutcliffe JS Richards S Verkerk AJMH Holden JJA Fenwick RG Warren ST Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox Cell 67 1991 1047
3. Yu S Pritchard M Kermer E Lynch M Nancarrow J Baker E Holman K Mulley JC Warren ST Schlessinger D Fragile X genotype characterized by an unstable region of DNA Science 252 1991 1179
4. Eichler EE Holden JA Popovich BW Reiss AL Snow K Thibodeau SN Richards CS Ward PA Nelson DL Length of uninterrupted CGG repeats determines instability in the FMR1 gene Nature Genet 8 1994 88
5. Kunst CB Warren ST Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles Cell 77 1994 853
6. Snow K Tester DJ Kruckeberg KE Schaid DJ Thibodeau SN Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation Hum Mol Genet 3 1994 1543
7. Snow K Doud LK Hagerman R Pergolizzi RG Erster SH Thibodeau SN Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population Am J Hum Gen 53 1993 1217
8. Hirst MC Grewal PK Davies KE Precursor arrays for triplet repeat expansion at the fragile X locus Hum Mol Genet 3 1994 1553
9. Pieretti M Zhang F Fu YH Warren ST Oostra BA Caskey CT Nelson DL Absence of expression of the FMR-1 gene in fragile X syndrome Cell 66 1991 817
10. Sutcliffe JS Nelson DL Zhang F Pieretti M Caskey CT Saxe D Warren ST DNA methylation represses FMR-1 transcription in fragile X syndrome Hum Mol Genet 1 1992 397
11. McConkie-Rosell A Lachiewicz AM Spiridigliozzi GA Tarleton J Schoenwald S Phelan MC Goonewardena P Ding X Brown WT Evidence that methylation of the FMR-1 locus is responsible for variable phenotypic expression of the fragile X syndrome Am J Hum Gen 53 1993 800
12. Ashley CT Wilkinson KD Reines D Warren ST FMR 1 protein: conserved RNP family domains and selective RNA binding Science 262 1993 563
13. Wolff PH Gardner J Lappen J Paccia J Meryash D Variable expression of the fragile X syndrome in heterozygous females of normal intelligence Am J Med Genet 30 1988 213
14. Rousseau F Heitz D Tarleton J Macpherson J Malmgren H Dahl N Barnicoat A A multicenter study on genotype-phenotype correlations in fragile X syndrome, using direct diagnosis with probe StB128: the first 2253 cases Am J Hum Genet 55 1994 225
15. Wohrle D Hirst MC Kennerknecht I Davies KE Steinbach P Genotype mosaicism in fragile X fetal tissues Hum Genet 89 1992 114
16. Yu S Mulley J Loesch D Turner G Donnelly A Gedeon A Hillen D Kremer E Lynch M Pritchard M Fragile-X syndrome: unique genetics of the heritable unstable element Am J Hum Genet 50 1992 968
17. Heitz D Devys D Imbert G Kretz C Mandel JL Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation J Med Genet 29 1992 794
18. Fisch GS Snow K Thibodeau SN Chalifaux M Holden JJA Nelson DE Howard-Peebles PN Maddalena A The fragile X premutation in carriers and its effect on mutation size in offspring Am J Hum Genet 56 1995 1147
19. Andrews LB Fullarton JE Holtzman NA Motulsky AG Assessing Genetic Risk Implications for Health and Social Policy 1994 National Academy Press Washington, D.C.
20. Committee for the Study of Inborn Errors of Metabolism Genetic Screening Programs, Principles, and Research 1975 National Academy of Sciences Washington, D.C.
21. Reilly P Genetics, Law and Social Policy 1977 Harvard University Press Cambridge, Massachusetts
22. Hilton B Callahan D Harris M Condliffe P Berkley B Ethical Issues in Human Genetics 1973 Plenum Press New York, London
23. Wilfond BS Nolan K National policy development for the clinical application of genetic diagnostic technologies Lessons from cystic fibrosis JAMA 270 1993 2948
24. Lilienfeld AM Huang PC Genetic Issues in Public Health and Medicine 1978 Charles C. Thomas Springfield, Illinois
25. Wilfond BS Fost N The introduction of cystic fibrosis carrier screening into clinical practice: policy considerations Milbank Q 70 1992 629
26. Kaback MM Tay-Sachs Disease: screening and prevention 1977 Alan R. Liss New York
27. Milunsky A Annas GJ Genetics and the Law 1976 Plenum Press New York
28. Cairns JA Shackley P Assessing value for money in medical screening J Med Screen 1 1994 39
29. Sherman SL Epidemiology Hagerman RJ Silverman Cronister A Fragile X syndrome: diagnosis, treatment and research 1991 The Johns Hopkins University Press Baltimore and London 69 97
30. Hagerman RJ Physical Behavioral Phenotype Hagerman RJ Silverman Cronister A Fragile X Syndrome: diagnosis treatment and research 1991 The John Hopkins University Press Baltimore and London 3 68
31. Cronister A Schreiner R Wittenberger M Amiri K Harris K Hagerman RJ The heterozygous fragile X female: historical physical, cognitive and cytogenetic features Am J Med Genet 38 1991 269
32. Butler MG Mangrum T Gupta R Singh D A 15-item checklist for screening mentally retarded males for the fragile X syndrome Clin Genet 39 1991 347
33. Nolin SL Snider DA Jenkins EC Brown WT Krawczun M Stetka D Houck G Dobkin CS Strong G Smith-Dobransky G Fragile X screening program in New York state Am J Med Genet 38 1990 251
34. Lauria DP Webb MJ McKenzie P Hagerman RJ The economic impact of the fragile X syndrome on the state of Colorado International Fragile X Conference Proceedings 1 1992 393
35. in press Roy JC Johnsen J Breese K Hagerman RJ Fragile X Syndrome: What is the impact of diagnosis on families? Dev Brain Dis 1995
36. Scharfenaker S Hickman L Braden M An intergrated approach to intervention Hagerman R Silverman Cronister A Fragile X Syndrome: Diagnosis Treatment and Research 1991 The John Hopkins University Press Baltimore and London 327 372
37. Brown J Braden M Sobesky W The treatment of behavioral, emotional problems Hagerman R Silverman Cronister A Fragile X Syndrome: Diagnosis, Treatment and Research 1991 The John Hopkins University Press Baltimore and London 311 326
38. Pennington BF O'Conner RA Sudhalter V Toward a Neuropsychology of Fragile X Syndrome Hagerman RJ Cronister Silverman A Fragile X Syndrome: diagnosis treatment and research 1991 The John Hopkins University Press Baltimore and London 173 201
39. Brown WT Houck GE Jeziorowska A Levinson FN Ding X Dobkin C Zhong J Henderson J Sklower Brooks S Jenkins EC Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test JAMA 270 1993 1569
40. Palomaki GE Population based prenatal screening for the fragile X syndrome J Med Screen 1 1994 65
41. (submitted) Ashley AE Sherman SL Population dynamic of a meiotic/mitotic expansion model for the fragile X syndrome Am J Hum Gen 1995
42. Winter RM Population genetics implications of the premutation hypothesis for the generation of the fragile X mental retardation gene Hum Genet 75 1987 269
43. Kolehmainen K Population genetics of fragile X: a multiple allele model with variable risk of CGG repeat expansion Am J Med Genet 51 1994 428
44. Sved JA Laird CD Population genetic consequences of the fragile-X syndrome based on the X-inactivation imprinting model Am J Hum Genet 46 1990 443
45. Morton NE Macpherson JN Population genetics of the fragile-X syndrome: multiallelic model for the FMR1 locus Proc Natl Acad Sci 89 1992 4215
46. (in press) Howard-Peebles PN Fallon L Black SH Fragile X carrier screening in an obstetric population Dev Brain Dis 1995
47. Hagerman RJ Medical Follow-up, Pharmacotherapy Hagerman RJ Cronister Silverman A Fragile X Syndrome: Diagnosis, Treatment and Research 1991 The John Hopkins University Press Baltimore and London 282 310
48. Turner G Robinson H Laing S Purvis-Smith S Preventive screening for the fragile X syndrome N Engl J Med 315 1986 607
49. Turner G Robinson H Laing S Van Den Berk M Colley A Goddard A Sherman S Partington M Population screening for fragile X Lancet 339 1992 1210
50. Modell B Kuliev AM A scientific basis for cost-benefit analysis of genetics services Trends Genet 9 1993 46
51. Andrews LB Jaeger AS Confidentiality of genetic information in the workplace Am J Law Med 17 1991 75
52. Andrews L Legal aspects of genetic information Yale J Bio Med 64 1991 29
53. Beauchamp TL Childress JF Principles of Biomedical Ethics 1994 Oxford University Press New York
54. Knoppers BM Laberge CM Genetic Screening, From Newborns to DNA Typing 1990 Elsevier Science Publishers, B.V. Amsterdam
55. Wertz DC Fletcher JC Ethics and Human Genetics A Cross Cultural Perspective 1989 Springer-Verlag New York
56. Faden RR Beauchamp TL King NMP A History and Theory of Informed Consent 1986 Oxford University Press New York
57. Lippman A Prenatal genetic testing and screening: constructing needs and reinforcing inequities Am J Law Med 17 1991 15
58. Nelkin D Tancredi L Classify and control: genetic information in the schools Am J Law Med 17 1991 51
59. Gostin L Genetic discrimination: the use of genetically based diagnostic and prognostic tests by employers and insurers Am J Law Med 17 1991 109
60. Kessler S Psychological aspects of genetic counseling: VI, A critical review of the literature dealing with education and reproduction Am J Med Genet 34 1989 340
61. Wertz DC Sorenson JR Heeren TC Clients' interpretation of risks provided in genetic counseling Am J Hum Gen 39 1986 253
62. Natowicz MR Alper JS Genetic screening: triumphs problems and controversies J Pub Health Policy 12 1991 475
63. Lappe M Gustatson JM Roblin R Ethical and social issues in screening for genetic disease N Engl J Med 286 1972 1129
64. Saxton M Prenatal screening and discriminatory attitudes about disability Embryos, Ethics and Women's Rights 1988 217
65. Rona RJ Beech R Mandalia S Donnai D Kingston H Harris R Wilson O Axtell C Swan AV Kavanagh F The influence of genetic counselling in the era of DNA testing on knowledge, reproductive intentions and pyschological wellbeing Clin Genet 46 1994 198
66. Billings PR Kohn MA de Cuevas M Beckwith J Alper JS Natowicz MR Discrimination as a consequence of genetic testing Am J Hum Gen 50 1992 476
67. Park V Howard-Peebles P Sherman S Taylor A Wulfsberg E Policy Statement: American College of Medical Genetics Fragile X syndrome: diagnostic and carrier testing Am J Med Genet 53 1994 380
68. Howard-Peebles PN Maddalena A Spence WC Levinson G Fallon L Bick DP Black SH Schulman JD Fragile X screening: what is the real issue? Am J Med Genet 53 1994 382
69. Zeesman S Clow CL Cartier L Scriver CR A private view of heterozygosity: eight-year follow-up on carriers of the Tay-Sachs gene detected by high school screening in Montreal Am J Med Genet 18 1984 769
70. Childs B Gordis L Kaback MM Kazazian Jr Tay-Sachs screening: motives for participating and knowledge of genetics and probability Am J Hum Gen 28 1976 537
71. Rowley PT Fisher L Lipken Jr Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood Am J Hum Gen 31 1979 718
72. Scriver CR Bardanis M Carter L Clow CL Lancaster GA Ostrowsky JT B -thalassemia disease prevention: genetic medicine applied Am J Hum Gen 36 1984 1024
73. Modell B Ward RHT Fairweather DVI Effect of introducing antenatal diagnosis on reproductive behavior of families at risk for thalassemia major Brit Med J 280 1980 1347
74. Miller SR Schwartz RH Attitudes toward genetic testing of Amish, Mennonite and Hutterite families with cystic fibrosis Amer J Pub Health 82 1992 236
75. Watson EK Williamson R Chapple J Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the public Brit J Gen Pract 41 1991 237
76. Kenen RH Schmidt RM Stigmatization of carrier status: social implications of heterozygote genetic screening programs Amer J Pub Health 68 1978 1116
77. Marteau T van Duijn M Ellis I Effects of genetic screening on perceptions of health: a pilot study J Med Genet 29 1992 24